VR Logo

TeklaLife Sciences Investors (HQL) download report


Financial | Asset Management Companies

TeklaLife Sciences Investors (HQL) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC.

IPO Date: 04-May-1992

Principal Exec. Officer, Pres and Trustee: Dr. Daniel R. Omstead M.S, Ph.D.

Listing: NYSE: HQL

Country: United States

Headquarters: Boston, MA

Website: https://www.teklacap.com/hql.html

Key Facts

Market cap: $399.04 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-43.31 Mln

Cash: $0.29 Mln

Total Debt: $0.00 Mln

Insider's Holding: 0.00%

Liquidity: Low

52 Week range: $13.03 - 22.70

Shares outstanding: 25,144,000

10 Years Aggregate:

  • CFO: $-21.97 Mln
  • EBITDA: $828.43 Mln
  • Net Profit: $494.46 Mln

Stock Performance

Time Period TeklaLife Sciences Investors (HQL) S&P BSE Sensex S&P Small-Cap 600
YTD-16.771.85-9.40
1 month5.238.9011.02
3 months10.469.148.82
1 Year-26.388.76-6.43
3 Years-0.4416.4410.91
5 Years-4.4713.488.84
10 Years0.3512.9510.89
As on 11-Aug-2022
Year TeklaLife Sciences Investors (HQL) S&P Small-Cap 600 S&P BSE Sensex
2021-2.6325.2721.99
202013.319.5715.75
201915.3520.8614.38
2018-22.92-9.705.87
201715.5411.7327.91
2016-28.1324.741.95
2015-4.98-3.36-5.03